BCG Live vaccine clinical trials
Also written BCG TICE strain.
How each study uses BCG Live vaccine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the BCG Live vaccine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 21 Jun 1989 · Tice Bcg · BLA 102821 (FDA, Purple Book)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
National Institute of Allergy and Infectious Diseases (NIAID) (2) · University of Virginia (1)
Studies
Open first, then newest update. How each study uses BCG Live vaccine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)RecruitingPhase 2University of VirginiaNCT07094711Written as Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine
- Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy HumansWithdrawnPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT06845358Written as BCG TICE strain
- Challenge Model for Assessment of Human TB ImmunityCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT01868464Written as BCG TICE strain
Given beside what is tested · 1 — BCG Live vaccine is usual care or a partner of the new treatment
Codes
What other systems call BCG Live vaccine · ClinicalTrials.gg INT002221
- MeSH (NLM) C000732097BCG Live vaccineOne source NLM
- UNII (FDA) 2XQ558L16ZBACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGENConfirmed FDA, NLM
- RxNorm 221050One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000732097 | BCG Live vaccine | One source NLM |
| UNII (FDA) | 2XQ558L16Z | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | Confirmed FDA, NLM |
| RxNorm | 221050 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.